Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilisation Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral Therapy

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.2537
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search